Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Influenza

Free Subscription Articles published in J Immunol Retrieve available abstracts of 136 articles: HTML format

Single Articles

November 2024
1. TONG X, Deng Y, Cizmeci D, Fontana L, et al
   Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination.
   J Immunol. 2024 Nov 17:ji2200956. doi: 10.4049/jimmunol.2200956.
   PubMed     Abstract available
   
   
   May 2024
2. BOUCHER J, Gilbert C, Bose S, Tessier PA, et al
   S100A9: The Unusual Suspect Connecting Viral Infection and Inflammation.
   J Immunol. 2024;212:1523-1529.
   PubMed     Abstract available
   
   
   
3. SAITO S, Bozorgmehr N, Sligl W, Osman M, et al
   The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2-Infected Individuals with Severe Disease.
   J Immunol. 2024;212:1540-1552.
   PubMed     Abstract available
   
   
   April 2024
4. KUNDURA L, Cezar R, Ballongue E, Andre S, et al
   Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2 Infection: Consumption Rather than Primary Deficiency.
   J Immunol. 2024;212:1105-1112.
   PubMed     Abstract available
   
   
   
5. ABE K, Beer JC, Nguyen T, Ariyapala IS, et al
   Cross-Platform Comparison of Highly Sensitive Immunoassays for Inflammatory Markers in a COVID-19 Cohort.
   J Immunol. 2024;212:1244-1253.
   PubMed     Abstract available
   
   
   March 2024
6. LI W, Lin Y, Wang X, Yang H, et al
   Chicken UFL1 Restricts Avian Influenza Virus Replication by Disrupting the Viral Polymerase Complex and Facilitating Type I IFN Production.
   J Immunol. 2024 Mar 13:ji2300613. doi: 10.4049/jimmunol.2300613.
   PubMed     Abstract available
   
   
   
7. READ KA, Amici SA, Farsi S, Cutcliffe M, et al
   PRMT5 Promotes T follicular helper Cell Differentiation and Germinal Center Responses during Influenza Virus Infection.
   J Immunol. 2024 Mar 4:ji2300270. doi: 10.4049/jimmunol.2300270.
   PubMed     Abstract available
   
   
   
8. AL-AHMAD A
   Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
   J Immunol. 2024;212:753.
   PubMed    
   
   
   
9. MAINO A, Amen A, Plumas J, Bouquet L, et al
   Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell-Based Approach for the Expansion and Characterization of SARS-CoV-2-Specific T Cells.
   J Immunol. 2024;212:825-833.
   PubMed     Abstract available
   
   
   February 2024
10. TANDON P, Abrams ND, Avula LR, Carrick DM, et al
    Unraveling Links between Chronic Inflammation and Long COVID: Workshop Report.
    J Immunol. 2024;212:505-512.
    PubMed     Abstract available
    
    
    
11. BRADSHAW CM, Georgieva T, Tankersley TN, Taylor-Doyle T, et al
    Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection.
    J Immunol. 2024;212:523-528.
    PubMed     Abstract available
    
    
    
12. DHANUSHKODI NR, Prakash S, Quadiri A, Zayou L, et al
    Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models.
    J Immunol. 2024;212:576-585.
    PubMed     Abstract available
    
    
    
13. KAMMANN T, Gorin JB, Parrot T, Gao Y, et al
    Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies.
    J Immunol. 2024;212:389-396.
    PubMed     Abstract available
    
    
    November 2023
14. LOBBY JL, Danzy S, Holmes KE, Lowen AC, et al
    Both Humoral and Cellular Immunity Limit the Ability of Live Attenuated Influenza Vaccines to Promote T Cell Responses.
    J Immunol. 2023 Nov 20:ji2300343. doi: 10.4049/jimmunol.2300343.
    PubMed     Abstract available
    
    
    
15. EVANS JP, Liu SL
    Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies.
    J Immunol. 2023;211:1459-1467.
    PubMed     Abstract available
    
    
    October 2023
16. MA W, Loving CL, Driver JP
    From Snoot to Tail: A Brief Review of Influenza Virus Infection and Immunity in Pigs.
    J Immunol. 2023;211:1187-1194.
    PubMed     Abstract available
    
    
    
17. DIAZ FE, McGill JL
    Modeling Human Respiratory Syncytial Virus (RSV) Infection: Recent Contributions and Future Directions Using the Calf Model of Bovine RSV Disease.
    J Immunol. 2023;211:1180-1186.
    PubMed     Abstract available
    
    
    
18. NOORUZZAMAN M, Diel DG
    Infection Dynamics, Pathogenesis, and Immunity to SARS-CoV-2 in Naturally Susceptible Animal Species.
    J Immunol. 2023;211:1195-1201.
    PubMed     Abstract available
    
    
    
19. ROSENBERG-HASSON Y, Holmes TH, Diray-Arce J, Chen J, et al
    Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients.
    J Immunol. 2023;211:1224-1231.
    PubMed     Abstract available
    
    
    September 2023
20. LUCKE J, Heinrich F, Malsy J, Meins N, et al
    Intestinal IL-1beta Plays a Role in Protecting against SARS-CoV-2 Infection.
    J Immunol. 2023;211:1052-1061.
    PubMed     Abstract available
    
    
    August 2023
21. SANDBERG JK, Leeansyah E, Eller MA, Shacklett BL, et al
    The Emerging Role of MAIT Cell Responses in Viral Infections.
    J Immunol. 2023;211:511-517.
    PubMed     Abstract available
    
    
    
22. CAO L, Hui X, Xu T, Mao H, et al
    The RNA-Splicing Ligase RTCB Promotes Influenza A Virus Replication by Suppressing Innate Immunity via Interaction with RNA Helicase DDX1.
    J Immunol. 2023 Aug 9:ji2200799. doi: 10.4049/jimmunol.2200799.
    PubMed     Abstract available
    
    
    July 2023
23. YU H, Worrall LJ, Berger T, Petric M, et al
    Identification of an optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2.
    J Immunol. 2023 Jul 26:ji2300282. doi: 10.4049/jimmunol.2300282.
    PubMed     Abstract available
    
    
    
24. LAW JC, Watts TH
    Considerations for Choosing T Cell Assays during a Pandemic.
    J Immunol. 2023;211:169-174.
    PubMed     Abstract available
    
    
    
25. PONDE NO, Shoger KE, Khatun MS, Sarkar MK, et al
    SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor.
    J Immunol. 2023;211:252-260.
    PubMed     Abstract available
    
    
    June 2023
26. CHEUNG MW, Dayam RM, Shapiro JR, Law JC, et al
    Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
    J Immunol. 2023 Jun 16:ji2300190. doi: 10.4049/jimmunol.2300190.
    PubMed     Abstract available
    
    
    
27. MAMBELLI F, Marinho FV, Andrade JM, de Araujo ACVSC, et al
    Recombinant Bacillus Calmette-Guerin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge.
    J Immunol. 2023;210:1925-1937.
    PubMed     Abstract available
    
    
    
28. PAIDI RK, Jana M, Raha S, Mishra RK, et al
    Prenol, but Not Vitamin C, of Fruit Binds to SARS-CoV-2 Spike S1 to Inhibit Viral Entry: Implications for COVID-19.
    J Immunol. 2023;210:1938-1949.
    PubMed     Abstract available
    
    
    
29. NAM H, Koh JY, Jung JH, Jeong H, et al
    Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19.
    J Immunol. 2023;210:1687-1699.
    PubMed     Abstract available
    
    
    May 2023
30. PHAN JM, Layton ED, Yu KKQ, Aguilar MS, et al
    Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2.
    J Immunol. 2023;210:1236-1246.
    PubMed     Abstract available
    
    
    March 2023
31. FINN CM, Dhume K, Prokop E, Strutt TM, et al
    STAT1 Controls the Functionality of Influenza-Primed CD4 T Cells but Therapeutic STAT4 Engagement Maximizes Their Antiviral Impact.
    J Immunol. 2023 Mar 24:ji2200407. doi: 10.4049/jimmunol.2200407.
    PubMed     Abstract available
    
    
    
32. HEMANN EA, Knoll ML, Wilkins CR, Subra C, et al
    A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.
    J Immunol. 2023 Mar 20:ji2300026. doi: 10.4049/jimmunol.2300026.
    PubMed     Abstract available
    
    
    
33. VAN DE WALL S, Crooks S, Varga SM, Badovinac VP, et al
    Cutting Edge: Influenza-Induced CD11alo Airway CD103+ Tissue Resident Memory T Cells Exhibit Compromised IFN-gamma Production after In Vivo TCR Stimulation.
    J Immunol. 2023 Mar 13:ji2200931. doi: 10.4049/jimmunol.2200931.
    PubMed     Abstract available
    
    
    
34. ZHAO Y, Xiao W, Wu Y, Fan W, et al
    Parallel T Cell Immunogenic Regions in Influenza B and A Viruses with Distinct Nuclear Export Signal Functions: The Balance between Viral Life Cycle and Immune Escape.
    J Immunol. 2023 Mar 10:ji2200243. doi: 10.4049/jimmunol.2200243.
    PubMed     Abstract available
    
    
    
35. SHAMSELDIN MM, Kenney A, Zani A, Evans JP, et al
    Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.
    J Immunol. 2023 Mar 6:ji2200297. doi: 10.4049/jimmunol.2200297.
    PubMed     Abstract available
    
    
    February 2023
36. VON RICHTHOFEN HJ, Westerlaken GHA, Gollnast D, Besteman S, et al
    Soluble Signal Inhibitory Receptor on Leukocytes-1 Is Released from Activated Neutrophils by Proteinase 3 Cleavage.
    J Immunol. 2023;210:389-397.
    PubMed     Abstract available
    
    
    
37. QUINN M, Parra-Rodriguez L, Alsoussi WB, Ayres C, et al
    Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination.
    J Immunol. 2023 Feb 13:ji2200920. doi: 10.4049/jimmunol.2200920.
    PubMed     Abstract available
    
    
    
38. SEREZANI CH, Divangahi M, Peters-Golden M
    Leukotrienes in Innate Immunity: Still Underappreciated after All These Years?
    J Immunol. 2023;210:221-227.
    PubMed     Abstract available
    
    
    January 2023
39. NG T, Flores-Malavet V, Mansoor MAM, Arvelo AC, et al
    Intermediate Levels of Pre-Existing Protective Antibody Allow Priming of Protective T Cell Immunity against Influenza.
    J Immunol. 2023 Jan 16:ji2200393. doi: 10.4049/jimmunol.2200393.
    PubMed     Abstract available
    
    
    December 2022
40. MISE-OMATA S, Ikeda M, Takeshita M, Uwamino Y, et al
    Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant.
    J Immunol. 2022;209:2104-2113.
    PubMed     Abstract available
    
    
    November 2022
41. ZHENG MZM, Fritzlar S, Wang Z, Tan TK, et al
    Cutting Edge: High-Dose Live Attenuated Influenza Vaccines Elicit Pulmonary Tissue-Resident Memory CD8+ T Cells in the Face of Pre-Existing Humoral Immunity.
    J Immunol. 2022;209:1832-1836.
    PubMed     Abstract available
    
    
    
42. BREZNIK JA, Huynh A, Zhang A, Bilaver L, et al
    Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination.
    J Immunol. 2022;209:1892-1905.
    PubMed     Abstract available
    
    
    
43. LOBBY JL, Uddback I, Scharer CD, Mi T, et al
    Persistent Antigen Harbored by Alveolar Macrophages Enhances the Maintenance of Lung-Resident Memory CD8(+) T Cells.
    J Immunol. 2022;209:1778-1787.
    PubMed     Abstract available
    
    
    October 2022
44. MILLER D, Garcia-Flores V, Romero R, Galaz J, et al
    Single-Cell Immunobiology of the Maternal-Fetal Interface.
    J Immunol. 2022;209:1450-1464.
    PubMed     Abstract available
    
    
    
45. SHOOK LL, Fourman LT, Edlow AG
    Immune Responses to SARS-CoV-2 in Pregnancy: Implications for the Health of the Next Generation.
    J Immunol. 2022;209:1465-1473.
    PubMed     Abstract available
    
    
    
46. ADHIKARI A, Abayasingam A, Rodrigo C, Agapiou D, et al
    Longitudinal Characterization of Phagocytic and Neutralization Functions of Anti-Spike Antibodies in Plasma of Patients after Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Immunol. 2022;209:1499-1512.
    PubMed     Abstract available
    
    
    
47. ZHENG MZM, Fritzlar S, Wang Z, Tan TK, et al
    Cutting Edge: High-Dose Live Attenuated Influenza Vaccines Elicit Pulmonary Tissue-Resident Memory CD8(+) T Cells in the Face of Pre-Existing Humoral Immunity.
    J Immunol. 2022 Oct 5. pii: jimmunol.2200577. doi: 10.4049/jimmunol.2200577.
    PubMed     Abstract available
    
    
    
48. PENG X, Kim J, Gupta G, Agaronyan K, et al
    Coronavirus Lung Infection Impairs Host Immunity against Secondary Bacterial Infection by Promoting Lysosomal Dysfunction.
    J Immunol. 2022;209:1314-1322.
    PubMed     Abstract available
    
    
    
49. SCHWARZ B, Roberts LM, Bohrnsen E, Jessop F, et al
    Contribution of Lipid Mediators in Divergent Outcomes following Acute Bacterial and Viral Lung Infections in the Obese Host.
    J Immunol. 2022;209:1323-1334.
    PubMed     Abstract available
    
    
    September 2022
50. BREZNIK JA, Huynh A, Zhang A, Bilaver L, et al
    Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination.
    J Immunol. 2022 Sep 28. pii: jimmunol.2200369. doi: 10.4049/jimmunol.2200369.
    PubMed     Abstract available
    
    
    August 2022
51. LUAN Y, Yuan Q, Wang Q, Compton S, et al
    Pazopanib Is a Potential Treatment for Coronavirus-Induced Lung Injuries.
    J Immunol. 2022;209:723-730.
    PubMed     Abstract available
    
    
    
52. CAMPANA S, De Pasquale C, Sidoti Migliore G, Pezzino G, et al
    Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients.
    J Immunol. 2022;209:655-659.
    PubMed     Abstract available
    
    
    
53. DAI M, Sun H, Zhao L, Wu Q, et al
    Duck CD8(+) T Cell Response to H5N1 Highly Pathogenic Avian Influenza Virus Infection In Vivo and In Vitro.
    J Immunol. 2022 Aug 8. pii: jimmunol.2101147. doi: 10.4049/jimmunol.2101147.
    PubMed     Abstract available
    
    
    
54. CIPOLLA EM, Yue M, Nickolich KL, Huckestein BR, et al
    Heterotypic Influenza Infections Mitigate Susceptibility to Secondary Bacterial Infection.
    J Immunol. 2022 Aug 1. pii: jimmunol.2200261. doi: 10.4049/jimmunol.2200261.
    PubMed     Abstract available
    
    
    July 2022
55. PEREZ MM, Pimentel VE, Fuzo CA, da Silva-Neto PV, et al
    Acetylcholine, Fatty Acids, and Lipid Mediators Are Linked to COVID-19 Severity.
    J Immunol. 2022;209:250-261.
    PubMed     Abstract available
    
    
    
56. PALANI S, Bansal S, Verma AK, Bauer C, et al
    Type I IFN Signaling Is Essential for Preventing IFN-gamma Hyperproduction and Subsequent Deterioration of Antibacterial Immunity during Postinfluenza Pneumococcal Infection.
    J Immunol. 2022;209:128-135.
    PubMed     Abstract available
    
    
    June 2022
57. CUSIMANO GM, Gary EN, Bell MR, Warner BM, et al
    Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1.
    J Immunol. 2022 Jun 24. pii: jimmunol.2200056. doi: 10.4049/jimmunol.2200056.
    PubMed     Abstract available
    
    
    
58. SEBINA I, Rashid RB, Sikder MAA, Rahman MM, et al
    IFN-lambda Diminishes the Severity of Viral Bronchiolitis in Neonatal Mice by Limiting NADPH Oxidase-Induced PAD4-Independent NETosis.
    J Immunol. 2022;208:2806-2816.
    PubMed     Abstract available
    
    
    
59. CHEN Y, Ye Z, Zhang Y, Xie W, et al
    A Deep Learning Model for Accurate Diagnosis of Infection Using Antibody Repertoires.
    J Immunol. 2022;208:2675-2685.
    PubMed     Abstract available
    
    
    
60. NAGASHIMA K, Dzimianski JV, Han J, Abbadi N, et al
    The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines.
    J Immunol. 2022 Jun 13. pii: jimmunol.2101171. doi: 10.4049/jimmunol.2101171.
    PubMed     Abstract available
    
    
    
61. LOUIE AY, Tingling J, Dray E, Hussain J, et al
    Dietary Cholesterol Causes Inflammatory Imbalance and Exacerbates Morbidity in Mice Infected with Influenza A Virus.
    J Immunol. 2022;208:2523-2539.
    PubMed     Abstract available
    
    
    
62. JERGOVIC M, Coplen CP, Uhrlaub JL, Beitel SC, et al
    Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved.
    J Immunol. 2022;208:2461-2465.
    PubMed     Abstract available
    
    
    May 2022
63. TAN HX, Wragg KM, Kelly HG, Esterbauer R, et al
    Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil.
    J Immunol. 2022;208:2267-2271.
    PubMed     Abstract available
    
    
    
64. LI H, Zhao M, Zhang H, Quan C, et al
    Pneumonia Severity and Phase Linked to Virus-Specific T Cell Responses with Distinct Immune Checkpoints during pH1N1 Infection.
    J Immunol. 2022;208:2154-2162.
    PubMed     Abstract available
    
    
    April 2022
65. HOUSER CL, Lawrence BP
    The Aryl Hydrocarbon Receptor Modulates T Follicular Helper Cell Responses to Influenza Virus Infection in Mice.
    J Immunol. 2022 Apr 20. pii: jimmunol.2100936. doi: 10.4049/jimmunol.2100936.
    PubMed     Abstract available
    
    
    
66. GOMEZ-LOPEZ N, Romero R, Tao L, Gershater M, et al
    Distinct Cellular Immune Responses to SARS-CoV-2 in Pregnant Women.
    J Immunol. 2022;208:1857-1872.
    PubMed     Abstract available
    
    
    
67. YANG X, Rutkovsky AC, Zhou J, Zhong Y, et al
    Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients.
    J Immunol. 2022;208:1968-1977.
    PubMed     Abstract available
    
    
    
68. ZHAI B, Clarke K, Bauer DL, Moehling Geffel KK, et al
    SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients.
    J Immunol. 2022;208:1711-1718.
    PubMed     Abstract available
    
    
    March 2022
69. JEONG S, Jeon M, Lee H, Kim SY, et al
    IFITM3 Is Upregulated Characteristically in IL-15-Mediated Bystander-Activated CD8(+) T Cells during Influenza Infection.
    J Immunol. 2022 Mar 28. pii: jimmunol.2100629. doi: 10.4049/jimmunol.2100629.
    PubMed     Abstract available
    
    
    
70. DHUME K, Finn CM, Devarajan P, Singh A, et al
    Bona Fide Th17 Cells without Th1 Functional Plasticity Protect against Influenza.
    J Immunol. 2022 Mar 25. pii: jimmunol.2100801. doi: 10.4049/jimmunol.2100801.
    PubMed     Abstract available
    
    
    
71. COSTANTINI VP, Nguyen K, Lyski Z, Novosad S, et al
    Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG.
    J Immunol. 2022;208:1500-1508.
    PubMed     Abstract available
    
    
    
72. HAZAN G, Eubanks A, Gierasch C, Atkinson J, et al
    Age-Dependent Reduction in Asthmatic Pathology through Reprogramming of Postviral Inflammatory Responses.
    J Immunol. 2022;208:1467-1482.
    PubMed     Abstract available
    
    
    
73. GAO X, Zhu B, Wu Y, Li C, et al
    TFAM-Dependent Mitochondrial Metabolism Is Required for Alveolar Macrophage Maintenance and Homeostasis.
    J Immunol. 2022;208:1456-1466.
    PubMed     Abstract available
    
    
    
74. YUZEFPOLSKIY Y, Morawski P, Fahning M, Speake C, et al
    Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.
    J Immunol. 2022 Mar 14. pii: jimmunol.2101142. doi: 10.4049/jimmunol.2101142.
    PubMed     Abstract available
    
    
    February 2022
75. MEYER-ARNDT L, Schwarz T, Loyal L, Henze L, et al
    Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4(+) T Cells following BNT162b2 Vaccination in the Elderly.
    J Immunol. 2022 Feb 4. pii: jimmunol.2100990. doi: 10.4049/jimmunol.2100990.
    PubMed     Abstract available
    
    
    
76. NICOLI F, Cabral-Piccin MP, Papagno L, Gallerani E, et al
    Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8(+) T Cells in Elderly Humans.
    J Immunol. 2022;208:562-570.
    PubMed     Abstract available
    
    
    
77. SUI C, Xiao T, Zhang S, Zeng H, et al
    SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy.
    J Immunol. 2022;208:753-761.
    PubMed     Abstract available
    
    
    
78. DUTT TS, LaVergne SM, Webb TL, Baxter BA, et al
    Comprehensive Immune Profiling Reveals CD56(+) Monocytes and CD31(+) Endothelial Cells Are Increased in Severe COVID-19 Disease.
    J Immunol. 2022;208:685-696.
    PubMed     Abstract available
    
    
    January 2022
79. KOMISSAROV AA, Dolzhikova IV, Efimov GA, Logunov DY, et al
    Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine.
    J Immunol. 2022 Jan 31. pii: jimmunol.2101052. doi: 10.4049/jimmunol.2101052.
    PubMed     Abstract available
    
    
    
80. TU MK, Chiang SH, Bender RA, Wong DTW, et al
    The Kinetics of COVID-19 Vaccine Response in a Community-Vaccinated Population.
    J Immunol. 2022 Jan 17. pii: jimmunol.2100919. doi: 10.4049/jimmunol.2100919.
    PubMed     Abstract available
    
    
    
81. LAW JC, Girard M, Chao GYC, Ward LA, et al
    Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset.
    J Immunol. 2022;208:429-443.
    PubMed     Abstract available
    
    
    
82. HOPE JL, Zhao M, Stairiker CJ, Kiernan CH, et al
    MicroRNA-139 Expression Is Dispensable for the Generation of Influenza-Specific CD8(+) T Cell Responses.
    J Immunol. 2022 Jan 12. pii: jimmunol.2000621. doi: 10.4049/jimmunol.2000621.
    PubMed     Abstract available
    
    
    
83. HARTWIG SM, Miller AM, Varga SM
    Respiratory Syncytial Virus Provides Protection against a Subsequent Influenza A Virus Infection.
    J Immunol. 2022 Jan 12. pii: jimmunol.2000751. doi: 10.4049/jimmunol.2000751.
    PubMed     Abstract available
    
    
    
84. WU B, Ramaiah A, Garcia G Jr, Hasiakos S, et al
    ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling.
    J Immunol. 2022;208:74-84.
    PubMed     Abstract available
    
    
    November 2021
85. LIU Y, Budylowski P, Dong S, Li Z, et al
    SARS-CoV-2-Reactive Mucosal B Cells in the Upper Respiratory Tract of Uninfected Individuals.
    J Immunol. 2021;207:2581-2588.
    PubMed     Abstract available
    
    
    
86. HUSSAIN SA, Rohlfing M, Resiliac J, Santoro J, et al
    Atopic Neutrophils Prevent Postviral Airway Disease.
    J Immunol. 2021;207:2589-2597.
    PubMed     Abstract available
    
    
    
87. JEEWANDARA C, Guruge D, Pushpakumara PD, Kamaladasa A, et al
    Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka.
    J Immunol. 2021 Nov 8. pii: jimmunol.2100762. doi: 10.4049/jimmunol.2100762.
    PubMed     Abstract available
    
    
    
88. GAJANAYAKA N, Dong SXM, Ali H, Iqbal S, et al
    TLR-4 Agonist Induces IFN-gamma Production Selectively in Proinflammatory Human M1 Macrophages through the PI3K-mTOR- and JNK-MAPK-Activated p70S6K Pathway.
    J Immunol. 2021;207:2310-2324.
    PubMed     Abstract available
    
    
    October 2021
89. WANG Y, Karki R, Zheng M, Kancharana B, et al
    Cutting Edge: Caspase-8 Is a Linchpin in Caspase-3 and Gasdermin D Activation to Control Cell Death, Cytokine Release, and Host Defense during Influenza A Virus Infection.
    J Immunol. 2021 Oct 18. pii: jimmunol.2100757. doi: 10.4049/jimmunol.2100757.
    PubMed     Abstract available
    
    
    
90. BANSAL S, Perincheri S, Fleming T, Poulson C, et al
    Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines.
    J Immunol. 2021 Oct 15. pii: jimmunol.2100637. doi: 10.4049/jimmunol.2100637.
    PubMed     Abstract available
    
    
    
91. PAIDI RK, Jana M, Mishra RK, Dutta D, et al
    Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
    J Immunol. 2021 Oct 13. pii: jimmunol.2100144. doi: 10.4049/jimmunol.2100144.
    PubMed     Abstract available
    
    
    
92. YANG Q, Wen Y, Qi F, Gao X, et al
    Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19.
    J Immunol. 2021;207:1848-1856.
    PubMed     Abstract available
    
    
    
93. SCOTT J, Ruchaud-Sparagano MH, Musgrave K, Roy AI, et al
    Phosphoinositide 3-Kinase delta Inhibition Improves Neutrophil Bacterial Killing in Critically Ill Patients at High Risk of Infection.
    J Immunol. 2021;207:1776-1784.
    PubMed     Abstract available
    
    
    September 2021
94. ALVES I, Vicente MM, Gaifem J, Fernandes A, et al
    SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis.
    J Immunol. 2021;207:1591-1598.
    PubMed     Abstract available
    
    
    
95. 
    Top Reads.
    J Immunol. 2021;207:1495.
    PubMed    
    
    
    
96. MA T, Ryu H, McGregor M, Babcock B, et al
    Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8(+) T Cells during Convalescence.
    J Immunol. 2021;207:1344-1356.
    PubMed     Abstract available
    
    
    August 2021
97. SHAHBAZ S, Xu L, Sligl W, Osman M, et al
    The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated.
    J Immunol. 2021;207:1099-1111.
    PubMed     Abstract available
    
    
    
98. OCHSNER SP, Li W, Rajendrakumar AM, Palaniyandi S, et al
    FcRn-Targeted Mucosal Vaccination against Influenza Virus Infection.
    J Immunol. 2021 Aug 11. pii: jimmunol.2100297. doi: 10.4049/jimmunol.2100297.
    PubMed     Abstract available
    
    
    
99. VERMA AK, Bauer C, Palani S, Metzger DW, et al
    IFN-gamma Drives TNF-alpha Hyperproduction and Lethal Lung Inflammation during Antibiotic Treatment of Postinfluenza Staphylococcus aureus Pneumonia.
    J Immunol. 2021 Aug 11. pii: jimmunol.2100328. doi: 10.4049/jimmunol.2100328.
    PubMed     Abstract available
    
    
    
100. REYNOLDS D, Vazquez Guillamet C, Day A, Borcherding N, et al
     Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.
     J Immunol. 2021 Aug 4. pii: jimmunol.2100294. doi: 10.4049/jimmunol.2100294.
     PubMed     Abstract available
     
     
     
101. BAYARRI-OLMOS R, Idorn M, Rosbjerg A, Perez-Alos L, et al
     SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.
     J Immunol. 2021;207:878-887.
     PubMed     Abstract available
     
     
     July 2021
102. AVENDANO-ORTIZ J, Lozano-Rodriguez R, Martin-Quiros A, Maroun-Eid C, et al
     SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.
     J Immunol. 2021;207:162-174.
     PubMed     Abstract available
     
     
     
103. 
     Top Reads.
     J Immunol. 2021;207:1-2.
     PubMed    
     
     
     June 2021
104. MATCHETT WE, Joag V, Stolley JM, Shepherd FK, et al
     Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.
     J Immunol. 2021 Jun 30. pii: jimmunol.2100421. doi: 10.4049/jimmunol.2100421.
     PubMed     Abstract available
     
     
     
105. MARTINI V, Paudyal B, Chrun T, McNee A, et al
     Correction: Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs.
     J Immunol. 2021 Jun 18. pii: jimmunol.2100261. doi: 10.4049/jimmunol.2100261.
     PubMed    
     
     
     
106. LIU X, Zhao J, Wang H, Wang W, et al
     Metabolic Defects of Peripheral T Cells in COVID-19 Patients.
     J Immunol. 2021;206:2900-2908.
     PubMed     Abstract available
     
     
     
107. 
     Top Reads.
     J Immunol. 2021;206:2773-2774.
     PubMed    
     
     
     
108. HOEHN KB, Ramanathan P, Unterman A, Sumida TS, et al
     Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19.
     J Immunol. 2021;206:2785-2790.
     PubMed     Abstract available
     
     
     
109. SANDOR AM, Sturdivant MS, Ting JPY
     Influenza Virus and SARS-CoV-2 Vaccines.
     J Immunol. 2021;206:2509-2520.
     PubMed     Abstract available
     
     
     
110. JAHRSDORFER B, Gross R, Seidel A, Wettstein L, et al
     Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors.
     J Immunol. 2021;206:2614-2622.
     PubMed     Abstract available
     
     
     
111. MANTUS G, Nyhoff LE, Kauffman RC, Edara VV, et al
     Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain.
     J Immunol. 2021;206:2605-2613.
     PubMed     Abstract available
     
     
     May 2021
112. OCCHIGROSSI L, Rossin F, D'Eletto M, Farrace MG, et al
     Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis.
     J Immunol. 2021;206:2420-2429.
     PubMed     Abstract available
     
     
     
113. FUJIGAKI H, Inaba M, Osawa M, Moriyama S, et al
     Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients.
     J Immunol. 2021;206:2393-2401.
     PubMed     Abstract available
     
     
     
114. YAN Q, Li P, Ye X, Huang X, et al
     Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.
     J Immunol. 2021;206:2146-2159.
     PubMed     Abstract available
     
     
     April 2021
115. CROOKE PS 3RD, Tossberg JT, Porter KP, Aune TM, et al
     Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.
     J Immunol. 2021;206:1691-1696.
     PubMed     Abstract available
     
     
     
116. HUANG W, Li M, Luo G, Wu X, et al
     The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression.
     J Immunol. 2021;206:1597-1608.
     PubMed     Abstract available
     
     
     
117. RUPP J, Dreo B, Gutl K, Fessler J, et al
     T Cell Phenotyping in Individuals Hospitalized with COVID-19.
     J Immunol. 2021;206:1478-1482.
     PubMed     Abstract available
     
     
     
118. FRANZETTI M, Forastieri A, Borsa N, Pandolfo A, et al
     IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study.
     J Immunol. 2021;206:1569-1575.
     PubMed     Abstract available
     
     
     
119. PRICE MJ, Scharer CD, Kania AK, Randall TD, et al
     Conserved Epigenetic Programming and Enhanced Heme Metabolism Drive Memory B Cell Reactivation.
     J Immunol. 2021;206:1493-1504.
     PubMed     Abstract available
     
     
     March 2021
120. MALINCZAK CA, Parolia A, Fonseca W, Morris S, et al
     TSLP-Driven Chromatin Remodeling and Trained Systemic Immunity after Neonatal Respiratory Viral Infection.
     J Immunol. 2021;206:1315-1328.
     PubMed     Abstract available
     
     
     February 2021
121. TIAN J, Zhang M, Jin M, Zhang F, et al
     Repurposed Tocilizumab in Patients with Severe COVID-19.
     J Immunol. 2021;206:599-606.
     PubMed     Abstract available
     
     
     
122. ZELBA H, Worbs D, Harter J, Pieper N, et al
     A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4(+) and CD8(+) T Cells in COVID-19 Patients.
     J Immunol. 2021;206:580-587.
     PubMed     Abstract available
     
     
     January 2021
123. SCHWARZ B, Sharma L, Roberts L, Peng X, et al
     Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators.
     J Immunol. 2021;206:329-334.
     PubMed     Abstract available
     
     
     
124. JOAG V, Wijeyesinghe S, Stolley JM, Quarnstrom CF, et al
     Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses.
     J Immunol. 2021 Jan 13. pii: jimmunol.2001400. doi: 10.4049/jimmunol.2001400.
     PubMed     Abstract available
     
     
     
125. HANSEN CB, Jarlhelt I, Perez-Alos L, Hummelshoj Landsy L, et al
     SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.
     J Immunol. 2021;206:109-117.
     PubMed     Abstract available
     
     
     December 2020
126. MARTINI V, Paudyal B, Chrun T, McNee A, et al
     Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs.
     J Immunol. 2020 Dec 16. pii: jimmunol.2001086. doi: 10.4049/jimmunol.2001086.
     PubMed     Abstract available
     
     
     
127. VOGELZANG EH, Loeff FC, Derksen NIL, Kruithof S, et al
     Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19.
     J Immunol. 2020;205:3491-3499.
     PubMed     Abstract available
     
     
     
128. MARTINEZ-FLETA P, Alfranca A, Gonzalez-Alvaro I, Casasnovas JM, et al
     SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.
     J Immunol. 2020;205:3130-3140.
     PubMed     Abstract available
     
     
     
129. KELLAR GG, Reeves SR, Barrow KA, Debley JS, et al
     Juvenile, but Not Adult, Mice Display Increased Myeloid Recruitment and Extracellular Matrix Remodeling during Respiratory Syncytial Virus Infection.
     J Immunol. 2020;205:3050-3057.
     PubMed     Abstract available
     
     
     November 2020
130. LAW JC, Koh WH, Budylowski P, Lin J, et al
     Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile.
     J Immunol. 2020 Nov 18. pii: jimmunol.2001067. doi: 10.4049/jimmunol.2001067.
     PubMed     Abstract available
     
     
     
131. KALKAN YAZICI M, Koc MM, Cetin NS, Karaaslan E, et al
     Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19.
     J Immunol. 2020;205:2719-2725.
     PubMed     Abstract available
     
     
     
132. NOWILL AE, de Campos-Lima PO
     Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
     J Immunol. 2020;205:2566-2575.
     PubMed     Abstract available
     
     
     
133. BAUMGARTH N, Nikolich-Zugich J, Lee FE, Bhattacharya D, et al
     Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.
     J Immunol. 2020;205:2342-2350.
     PubMed     Abstract available
     
     
     
134. VARNAITE R, Garcia M, Glans H, Maleki KT, et al
     Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
     J Immunol. 2020;205:2437-2446.
     PubMed     Abstract available
     
     
     October 2020
135. ELAHI S
     Neonatal and Children's Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy.
     J Immunol. 2020;205:1990-1997.
     PubMed     Abstract available
     
     
     September 2020
136. SOKULSKY LA, Garcia-Netto K, Nguyen TH, Girkin JLN, et al
     A Critical Role for the CXCL3/CXCL5/CXCR2 Neutrophilic Chemotactic Axis in the Regulation of Type 2 Responses in a Model of Rhinoviral-Induced Asthma Exacerbation.
     J Immunol. 2020 Sep 18. pii: jimmunol.1901350. doi: 10.4049/jimmunol.1901350.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.